Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis
File version
Version of Record (VoR)
Author(s)
Kaiser, Marcel
Avery, Vicky M
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
The screening of a focused library identified FTY720 (Fingolimod; Gilenya) as a potent selective antitrypanosomal compound active against Trypanosoma brucei gambiense and T. brucei rhodesiense, the causative agents of human African trypanosomiasis (HAT). This is the first report of trypanocidal activity for FTY720, an oral drug registered for the treatment of relapsing multiple sclerosis, and the characterization of sphingolipids as a potential new class of compounds for HAT.
Journal Title
Antimicrobial Agents and Chemotherapy
Conference Title
Book Title
Edition
Volume
60
Issue
3
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
NHMRC
Grant identifier(s)
APP1067728
Rights Statement
Rights Statement
© 2016 American Society for Microbiology. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
Item Access Status
Note
Access the data
Related item(s)
Subject
Microbiology
Medical microbiology
Medical microbiology not elsewhere classified
Pharmacology and pharmaceutical sciences